Crossmark

Biology and therapeutic targeting of vascular endothelial growth factor A

Published Online: 2023-07-25

Published Print: 2023-11

Authors

Pérez-Gutiérrez, Lorena http://orcid.org/0000-0001-8135-4975
Ferrara, Napoleone
License Information

Text and Data Mining valid from 2023-07-25

Version of Record valid from 2023-07-25
More Information

Article History

Accepted: 16 June 2023

First Online: 25 July 2023

Competing interests

: N.F. is a co-founder of Theia Therapeutics and NVasc. L.P.-G. declares no competing interests.

Document is current